uniQure NV of the Netherlands has announced the appointment of Leonard Post to its board of directors. Dr Post, who will also chair the company’s research and development committee, has served as chief scientific officer of Vivace Therapeutics Inc and its sister company Virtuoso Therapeutics Inc since 2016. Prior to this, he was CSO at BioMarin Pharmaceutical Inc where he oversaw the development of the company’s gene therapy for haemophilia A. Dr Post trained as a virologist and holds a doctorate in biochemistry from the University of Wisconsin, US.
uniQure announced the appointment on 17 June 2020.
Copyright 2020 Evernow Publishing Ltd